0 items

in your cart
$0.00

  • Search for Medications
  • Viewcart | Checkout
  • Manage Account
  •  
  • Click-to-Call  

Prescription Drug Search

Product Request Form

Ofatumumab is currently not available.

Our suppliers are constantly updating their product inventory and availability status. If you would like us to notify you when Ofatumumab becomes available, please fill out the form below.

Name:
Email:

*We value your privacy! We will never give, lease, sell or otherwise disclose your personal information. Period!

Search for a drug:

 

Browse Alphabetically:

A · B · C · D · E · F · G · H · I · J · K · L · M · N
O · P · Q · R · S · T · U · V · W · X · Y · Z · #

Information about NationDrugs.to

SSL Secured Website Certified Global Pharmacy Network Hacker Proof: Safe Shopping Experience 5th Anniversary 2002-2007

List of countries where we can ship Ofatumumab:

  • Albania
  • Anguilla
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Bahrain
  • Bangladesh
  • Bermuda
  • Bolivia
  • Bosnia and Herzegovina
  • Bulgaria
  • Cayman Islands
  • Czech Republic
  • Finland
  • Grenada
  • Guatemala
  • Honduras
  • India
  • Italy
  • Jamaica
  • Korea, Republic of
  • Kuwait
  • Latvia
  • Nicaragua
  • Panama
  • Peru
  • Saint Lucia
  • Saudi Arabia
  • Seychelles
  • South Africa
  • Sweden
  • Taiwan
  • Tonga
  • Tunisia
  • Turkey
  • United Arab Emirates
  • United Kingdom, UK
  • United States, US
  • Uzbekistan
View All Countries

Latest news releases on Ofatumumab:

http://www.genmab.com/product-pipeline/products-in-development/ofatumumab

Vi ville gerne vise dig en beskrivelse her, men det websted, du kigger på, tillader det ikke.

Ofatumumab Uses, Side Effects & Warnings - Drugs.com

Physician reviewed ofatumumab patient information - includes ofatumumab description, dosage and directions.

Ofatumumab (Arzerra) Multiple Sclerosis | MS News Today

Ofatumumab (Arzerra) is an approved leukemia treatment marketed by Novartis and now in Phase 3 clinical tests for relapsing MS.

Ibrutinib versus Ofatumumab in Previously Treated Chronic ...

The new england journal of medicine n engl j med 371;3 nejm.org17, 2014 july 213 original article Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid ...

ARZERRA® (ofatumumab) | GSK

What we do. We aim to bring differentiated, high-quality and needed healthcare products to as many people as possible, with our three global businesses, scientific ...

Ibrutinib versus Ofatumumab in Previously Treated Chronic ...

Background In patients with chronic lymphoid leukemia (CLL) or small lymphocytic lymphoma (SLL), a short duration of response to therapy or adverse cytogenetic ...

Efficacy and Safety of Ofatumumab Compared to ...

Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis. (ASCLEPIOS II)

Ofatumumab and Bendamustine Combination Therapy Compared ...

The purpose of this study is to evaluate the safety and efficacy of ofatumumab and bendamustine combination therapy in patients with indolent B-cell NHL that did not ...

FDA Drug Safety Communication: Boxed Warning and new ...

The U.S. Food and Drug Administration (FDA) has approved changes to the prescribing information of the immune-suppressing and anti-cancer drugs Arzerra (ofatumumab ...

Subcutaneous Ofatumumab an Effective RRMS Therapy at Low Doses

A Phase 2 trial found that a subcutaneous formulation of ofatumumab is a safe and effective treatment at low doses for relapsing-remitting multiple sclerosis (RRMS).

Customer Service
1-866-799-3435 | Contact Form
Copyright © 2018 NationDrugs.to All rights reserved. Disclaimer | Privacy Policy
Accepted Credit Cards and Payment: VISA, MASTERCARD and eCHECK